RESUMO
Cataracts cause vision loss and blindness by impairing the ability of the ocular lens to focus light onto the retina. Various cataract risk factors have been identified, including drug treatments, age, smoking and diabetes. However, the molecular events responsible for these different forms of cataract are ill-defined, and the advent of modern cataract surgery in the 1960s virtually eliminated access to human lenses for research. Here, we demonstrate large-scale production of light-focusing human micro-lenses from spheroidal masses of human lens epithelial cells purified from differentiating pluripotent stem cells. The purified lens cells and micro-lenses display similar morphology, cellular arrangement, mRNA expression and protein expression to human lens cells and lenses. Exposing the micro-lenses to the emergent cystic fibrosis drug Vx-770 reduces micro-lens transparency and focusing ability. These human micro-lenses provide a powerful and large-scale platform for defining molecular disease mechanisms caused by cataract risk factors, for anti-cataract drug screening and for clinically relevant toxicity assays.
Assuntos
Aminofenóis/efeitos adversos , Catarata/induzido quimicamente , Catarata/metabolismo , Cristalino/metabolismo , Modelos Biológicos , Células-Tronco Pluripotentes/metabolismo , Quinolonas/efeitos adversos , Aminofenóis/farmacologia , Catarata/patologia , Humanos , Cristalino/patologia , Células-Tronco Pluripotentes/patologia , Quinolonas/farmacologiaRESUMO
Here we describe a modified method for harvesting tens-of-millions of human lens epithelial-like cells from differentiated pluripotent stem cell cultures. To assess the utility of this method, we analysed the lens cell population via: light microscopy; single cell RNA-sequencing and gene ontology analyses; formation of light-focusing micro-lenses; mass spectrometry; and electron microscopy. Both individually and collectively, the data indicate this simplified harvesting method provides a large-scale source of stem cell-derived lens cells and micro-lenses for investigating human lens and cataract formation.
Assuntos
Separação Celular/métodos , Células Epiteliais/citologia , Cristalino/citologia , Células-Tronco Pluripotentes/citologia , Diferenciação Celular , Células Epiteliais/metabolismo , Humanos , Cristalino/metabolismo , Espectrometria de Massas , Microscopia , Microscopia Eletrônica , Células-Tronco Pluripotentes/metabolismo , Receptores Órfãos Semelhantes a Receptor Tirosina Quinase/metabolismo , Análise de Sequência de RNAAssuntos
Centers for Medicare and Medicaid Services, U.S. , Planos de Incentivos Médicos , Médicos de Família , Reembolso de Incentivo , Benchmarking , Centers for Medicare and Medicaid Services, U.S./economia , Centers for Medicare and Medicaid Services, U.S./legislação & jurisprudência , Diabetes Mellitus , Humanos , Medicaid , Medicare , Indicadores de Qualidade em Assistência à Saúde , Sistema de Registros , Estados UnidosAssuntos
Medicina de Família e Comunidade/normas , Medicaid/normas , Medicare/normas , Médicos de Família/normas , Diabetes Mellitus Tipo 1/epidemiologia , Diabetes Mellitus Tipo 2/epidemiologia , Humanos , Planos de Incentivos Médicos , Garantia da Qualidade dos Cuidados de Saúde/métodos , Sistema de Registros/normas , Estados Unidos/epidemiologiaRESUMO
The increasing prevalence and use of herbal mixtures containing synthetic cannabinoids presents a growing public health concern and legal challenge for society. In contrast to the plant-derived cannabinoids in medical marijuana and other cannabinoid-based therapeutics, the commonly encountered synthetic cannabinoids in these mendaciously labeled products constitute a structurally diverse set of compounds of relatively unknown pharmacology and toxicology. Indeed, the use of these substances has been associated with an alarming number of hospitalizations and emergency room visits. Moreover, there are already several hundred known cannabinoid agonist compounds that could potentially be used for illicit purposes, posing an additional challenge for public health professionals and law enforcement efforts, which often require the detection and identification of the active ingredients for effective treatment or prosecution. A solid-phase microextraction headspace gas chromatography-mass spectrometry method is shown here to allow for rapid and reliable detection and structural identification of many of the synthetic cannabinoid compounds that are currently or could potentially be used in herbal smoking mixtures. This approach provides accelerated analysis and results that distinguish between structural analogs within several classes of cannabinoid compounds, including positional isomers. The analytical results confirm the continued manufacture and distribution of herbal materials with synthetic cannabinoids and provide insight into the manipulation of these products to avoid legal constraints and prosecution.